| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/23/2013 | CN103356594A Application of Chukrasone B in preparation medicines for treating aseptic inflammation |
| 10/23/2013 | CN103356593A Application of Chukrasone B in preparation of medicines for promoting insulin secretion |
| 10/23/2013 | CN103356592A Application of Chukrasone B in preparation medicines for reducing blood glucose |
| 10/23/2013 | CN103356591A Application of Chukrasone B in preparation of medicines for treating Alzheimer disease |
| 10/23/2013 | CN103356590A Application of Sarcaboside A in thrombocyte-increasing medicines |
| 10/23/2013 | CN103356589A Application of Sarcaboside A in preparation of drug for treating cervical cancer |
| 10/23/2013 | CN103356588A Application of Sarcaboside A in preparing medicine for treating or preventing renal fibrosis |
| 10/23/2013 | CN103356587A Application of Sarcaboside B in preparation of medicines for treating atherosclerosis |
| 10/23/2013 | CN103356586A Application of Sarcaboside B in medicine used for treating rheumatoid arthritis |
| 10/23/2013 | CN103356585A Application of Sarcaboside B in preparation of medicines for treating bladder cancer |
| 10/23/2013 | CN103356584A Application of Sarcaboside A in medicine for promoting small intestine peristalsis |
| 10/23/2013 | CN103356583A Application of Sarcaboside A in preparing anti-platelet aggregation medicine |
| 10/23/2013 | CN103356582A Application of Sarcaboside A in medicine for preventing liver injury |
| 10/23/2013 | CN103356581A Application of Sarcaboside A in preparation of drug for treating liver cancer |
| 10/23/2013 | CN103356580A Application of Sarcaboside A in medicine for preventing pancreatic fibrosis |
| 10/23/2013 | CN103356579A Application of Sarcaboside A in preparing medicine for preventing or treating renal insufficiency |
| 10/23/2013 | CN103356578A Application of Sarcaboside A in preparation of drug for treating bile duct carcinoma |
| 10/23/2013 | CN103356577A Application of Sarcaboside A in preparation of drug for treating stomach cancer |
| 10/23/2013 | CN103356576A Application of Sarcaboside A in preparation of drug for treating lung cancer |
| 10/23/2013 | CN103356575A Application of Sarcaboside A in preparation of drug for treating prostatic cancer |
| 10/23/2013 | CN103356574A Application of Sarcaboside B in preparation of drug for promoting intestinal peristalsis |
| 10/23/2013 | CN103356573A Application of Sarcaboside A in anti-hypoxia medicine |
| 10/23/2013 | CN103356572A Application of Sarcaboside B in preparation of medicines for treating osteoporosis caused by antiestrogen deficiency |
| 10/23/2013 | CN103356571A Application of Sarcaboside B in preparation of medicines for treating nasopharynx cancer |
| 10/23/2013 | CN103356570A Application of Sarcaboside B in medicine used for treating or preventing chronic heart failure |
| 10/23/2013 | CN103356569A Application of Sarcaboside B in medicine used for treating or preventing renal fibrosis |
| 10/23/2013 | CN103356568A Application of Sarcaboside A in preparing medicine for treating tongue cancer |
| 10/23/2013 | CN103356567A Application of Sarcaboside B in preparation of vascular dilation medicines |
| 10/23/2013 | CN103356566A Application of Sarcaboside B in leukocyte-increasing medicines |
| 10/23/2013 | CN103356565A Application of Sarcaboside B in preparation of drug for promoting insulin secretion |
| 10/23/2013 | CN103356564A Application of Sarcaboside B in preparation of medicines for preventing and treating liver damage |
| 10/23/2013 | CN103356563A Application of Sarcaboside B in medicines for resisting lung cancer metastasis |
| 10/23/2013 | CN103356562A Application of Sarcaboside B in preparation of medicines for resisting platelet aggregation |
| 10/23/2013 | CN103356561A Application of Sarcaboside B in medicine used for treating renal cancer |
| 10/23/2013 | CN103356560A Application of Sarcaboside B in medicine used for treating prostate cancer |
| 10/23/2013 | CN103356559A Application of Sarcaboside B in preparation of medicines for treating tongue cancer |
| 10/23/2013 | CN103356558A Application of Sarcaboside A in preparation of drug for treating alzheimer disease |
| 10/23/2013 | CN103356557A Application of Sarcaboside B in preparation of medicines for treating liver cancer |
| 10/23/2013 | CN103356556A Application of Sarcaboside B in medicines for treating leukemia |
| 10/23/2013 | CN103356555A Application of Sarcaboside A in erythrocyte-increasing medicines |
| 10/23/2013 | CN103356554A Application of Sarcaboside B in preparation of medicines for treating rhinitis |
| 10/23/2013 | CN103356553A Application of Sarcaboside A in preparation of drug for treating breast cancer |
| 10/23/2013 | CN103356552A Application of Sarcaboside B in preparation of medicines for treating endometrial cancer |
| 10/23/2013 | CN103356551A Application of Sarcaboside B in medicine used for treating ischemic brain injury |
| 10/23/2013 | CN103356550A Application of Sarcaboside B in medicine used for treating laryngeal cancer |
| 10/23/2013 | CN103356549A Application of Sarcaboside A in medicine for treating or preventing oral ulcer |
| 10/23/2013 | CN103356548A Application of Sarcaboside A in preparation of drug for treating or preventing chronic heart failure |
| 10/23/2013 | CN103356547A Application of Sarcaboside A in preparation of drug for treating skin cancer |
| 10/23/2013 | CN103356546A Application of Sarcaboside B in medicine used for treating myocardial ischemia |
| 10/23/2013 | CN103356545A Application of Sarcaboside B in medicine used for treating ovarian cancer |
| 10/23/2013 | CN103356544A Application of Sarcaboside B in monoamine oxidase inhibitor drug |
| 10/23/2013 | CN103356543A Application of Sarcaboside A in preparation of drug for treating acute renal failure |
| 10/23/2013 | CN103356542A Application of Sarcaboside B in preparation of medicines for treating lung cancer |
| 10/23/2013 | CN103356541A Application of Sarcaboside B in medicine used for treating gastric cancer |
| 10/23/2013 | CN103356540A Application of Sarcaboside A in medicine for promoting insulin secretion |
| 10/23/2013 | CN103356539A Application of Sarcaboside A in preparation of drug for treating colorectal cancer |
| 10/23/2013 | CN103356538A Application of Sarcaboside A in preparation of drug for treating ovarian cancer |
| 10/23/2013 | CN103356537A Application of Sarcaboside B in preparation of medicines for resisting aseptic inflammation |
| 10/23/2013 | CN103356536A Application of Sarcaboside A in preparation of drug for treating acute gout |
| 10/23/2013 | CN103356535A Application of Sarcaboside A in preparation of drug for treating pancreatic cancer |
| 10/23/2013 | CN103356534A Application of Sarcaboside B in medicine used for treating colorectal cancer |
| 10/23/2013 | CN103356533A Application of Sarcaboside A in medicine for inhibiting liver fibroblast proliferation |
| 10/23/2013 | CN103356532A Application of Sarcaboside B in medicine used for treating breast cancer |
| 10/23/2013 | CN103356531A Application of Sarcaboside B in medicine used for treating cervical cancer |
| 10/23/2013 | CN103356530A Application of Sarcaboside B in preparation of medicines for treating ileocecum cancer |
| 10/23/2013 | CN103356529A Application of Sarcaboside B in preparation of medicines for treating or preventing acute heart failure |
| 10/23/2013 | CN103356528A Application of Sarcaboside A in antidepressant medicine |
| 10/23/2013 | CN103356527A Application of Sarcaboside B in medicine used for treating acute renal failure |
| 10/23/2013 | CN103356526A Application of Sarcaboside A in preparation of drug for treating ischemic brain injury |
| 10/23/2013 | CN103356525A Application of Sarcaboside B in thrombocyte-increasing medicines |
| 10/23/2013 | CN103356524A Application of Sarcaboside B in medicine used for treating acute gout |
| 10/23/2013 | CN103356523A Application of Sarcaboside B in preparation of medicines for inhibiting liver fibroblast proliferation |
| 10/23/2013 | CN103356522A Application of Sarcaboside B in preparation of medicines for treating alzheimer disease |
| 10/23/2013 | CN103356521A Application of butylphthalide or derivatives thereof in preparation of medicaments for treating or preventing radiation brain damage |
| 10/23/2013 | CN103356520A Application of zearalenone type beta-resorcylic acid macrolide in prevention and treatment of bilharziasis |
| 10/23/2013 | CN103356519A Application of dihydromyricetin in induction of cancer cell autophagy |
| 10/23/2013 | CN103356518A Application of monocillin beta-resorcylic acid macrolide for preventing and treating schistosome diseases |
| 10/23/2013 | CN103356517A Application of Scopariusins in preparation of antibacterial medicines |
| 10/23/2013 | CN103356516A Small molecule anti-cancer drug based on mitogen-activated protein kinase kinase (MEK) and histone deacetylase (HDAC) double targets and preparation method of small molecule anti-cancer drug |
| 10/23/2013 | CN103356515A Application of emodin anthraquinone derivative in preparation of anti-hepatocellular carcinoma drugs |
| 10/23/2013 | CN103356514A Diarylalkanes as potent inhibitors of binuclear enzymes |
| 10/23/2013 | CN103356513A Applications of delta-elemene and derivative thereof in anti-atherosclerosis |
| 10/23/2013 | CN103356512A Benzenesulfonic acid amlodipine membranaceous preparation |
| 10/23/2013 | CN103356509A Film agent containing zolpidem serving as main active component |
| 10/23/2013 | CN103356507A Preparation method of all-trans tretinoin solid lipid nanoparticles |
| 10/23/2013 | CN103356506A Solid lipid nanoparticles of alendronate sodium and preparation method thereof |
| 10/23/2013 | CN103356504A 4-Amino-2-trifluoromethylphenylretinoate self-microemulsion and preparation method thereof |
| 10/23/2013 | CN103356503A Novel amlodipine and benazepril capsule |
| 10/23/2013 | CN103356502A Novel capsule filled with rosiglitazone solid preparation and metformin solid preparation |
| 10/23/2013 | CN103356501A Risperidone tablet and preparation method thereof |
| 10/23/2013 | CN103356500A Calcium rosuvastatin and fenofibric acid choline salt time-selecting osmotic pump controlled release tablet and preparation method thereof |
| 10/23/2013 | CN103356499A Dextran-MLDH-fluorouracil supermolecular assembly magnetic targeting sustained release tablet |
| 10/23/2013 | CN103356498A Mosapride citrate dehydrate sustained release tablet |
| 10/23/2013 | CN103356497A Benzenesulfonate amlodipine tablet and preparation method thereof |
| 10/23/2013 | CN103356496A Citric acid calcium malate drug tablet |
| 10/23/2013 | CN103356495A Letrozole tablet and preparation method thereof |
| 10/23/2013 | CN103356494A High-stability simvastatin tablets and preparation method thereof |
| 10/23/2013 | CN103356493A Preparation method of amlodipine besylate tablets |
| 10/23/2013 | CN103356492A Tripterine pharmaceutical composition using albumin as pharmaceutical carrier |
| 10/23/2013 | CN103356491A Preparation method of syringopicroside (SYR) poly(lactide-co-glycolide) (PLGA) nanoparticles |